CEDILLA THERAPEUTICS, INC.

Profile

Company Names

CEDILLA THERAPEUTICS, INC.

Addresses

245 FIRST STREET, CAMBRIDGE, MA 02142

38 SIDNEY STREET, FLOOR 2, CAMBRIDGE, MA 02139

Phone Numbers

617- 281-5658

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$82,599,996.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2020-09-09 
$82,599,996.00 
$82,599,996.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRIS 
 
BOWDEN 
DIRECTOR
CEDILLA THERAPEUTICS, INC.   |  ADYTON RESOURCES CORP
ELI 
 
CASDIN 
DIRECTOR
CASDIN PARTNERS, LP   |  CASDIN PARTNERS OFFSHORE, LTD.   |  CASDIN VENTURE OPPORTUNITIES FUND, L.P.   |  SINGULAR BIO, INC.   |  SEXTON BIOTECHNOLOGIES, INC.   |  C2I GENOMICS, INC.   |  CEDILLA THERAPEUTICS, INC.   |  ABSCI CORP   |  VINETI, INC.   |  CASDIN PRIVATE GROWTH EQUITY FUND, L.P.   |  SOMALOGIC, INC   |  PAIGE.AI, INC.   |  CENTURY THERAPEUTICS, INC.   |  GENOMATICA INC   |  CASDIN PRIVATE GROWTH EQUITY FUND II, L.P.
ABBIE 
 
CELNIKER 
DIRECTOR
TALIGEN THERAPEUTICS INC   |  IMAGINAB, INC.   |  THIRD ROCK VENTURES IV, L.P.   |  GOLDFINCH BIOPHARMA, INC.   |  RHEOS MEDICINES, INC.   |  PANOPTICA, INC.   |  THIRD ROCK VENTURES V, L.P.   |  GOLDFINCH BIO, INC.   |  CEDILLA THERAPEUTICS, INC.   |  ABATA THERAPEUTICS, INC.   |  THIRD ROCK VENTURES VI, L.P.
NEIL 
 
EXTER 
DIRECTOR
SEVENTH SENSE BIOSYSTEMS, INC.   |  CORIDEA NC1, INC.   |  CYTOMX THERAPEUTICS, INC.   |  ELEMENT SCIENCE, INC.   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  GOLDFINCH BIOPHARMA, INC.   |  PLIANT THERAPEUTICS, INC.   |  THIRD ROCK VENTURES V, L.P.   |  REVOLUTION MEDICINES, INC.   |  GOLDFINCH BIO, INC.   |  CEDILLA THERAPEUTICS, INC.   |  DECIBEL THERAPEUTICS, INC.   |  THIRD ROCK VENTURES VI, L.P.
ALEXANDRA 
 
GLUCKSMANN 
EXECUTIVE OFFICER, DIRECTOR
CERULEAN PHARMA INC.   |  EDITAS MEDICINE, INC.   |  CEDILLA THERAPEUTICS, INC.   |  SENSORIUM THERAPEUTICS, INC.
ROSANA 
 
KAPELLER 
DIRECTOR
CEDILLA THERAPEUTICS, INC.
DOMINIK 
 
NACZYNSKI 
DIRECTOR
CEDILLA THERAPEUTICS, INC.
JAKE 
 
SIMSON 
DIRECTOR
AAVANTIBIO, INC.   |  DICE MOLECULES HOLDINGS, LLC   |  CEDILLA THERAPEUTICS, INC.   |  CONVERGENT THERAPEUTICS, INC.   |  SEPTERNA, INC.   |  OUTPACE BIO, INC.   |  VIVACE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-10-25
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-09 
2021-09-09
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-09 
2020-09-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#